Quarterly report pursuant to Section 13 or 15(d)

Earnings (Loss) Per Common Share (Tables)

v3.8.0.1
Earnings (Loss) Per Common Share (Tables)
 6 Months Ended
Dec. 31, 2017
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
The following table summarizes the components of the earnings (loss) per common share calculation (in thousands, except per share amounts):
 
 
 
Three Months ended
December 31,
 
Six Months ended
December 31,
 
 
 
2017
 
2016
 
2017
 
2016
 
Basic and diluted numerator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss attributable to iBio, Inc.
 
$
(3,899)
 
$
(3,229)
 
$
(7,725)
 
$
(6,290)
 
Preferred stock dividends
 
 
65
 
 
-
 
 
131
 
 
-
 
Net loss available to iBio, Inc. stockholders
 
$
(3,964)
 
$
(3,229)
 
$
(7,856)
 
$
(6,290)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic and diluted denominator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted-average common shares outstanding
 
 
96,609
 
 
89,109
 
 
96,127
 
 
89,109
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Per share amount
 
$
(0.04)
 
$
(0.04)
 
$
(0.08)
 
$
(0.07)